We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




International Progress on Noncommunicable Diseases at Risk

By HospiMedica International staff writers
Posted on 08 Sep 2011
International progress on noncommunicable diseases (NCDs) such as cancer, diabetes, cardiovascular disease, and chronic respiratory disease is in jeopardy due to recent efforts by some member states to postpone and weaken ongoing negotiations at the United Nations (UN; New York, NY, USA).

In a letter addressed to UN Secretary General Ban Ki-moon, the NCD Alliance (Geneva, Switzerland), a coalition of over 2,000 organizations from over 170 countries focusing on NCDs, attacked the state of negotiations towards the first-ever UN High-Level Meeting on the Prevention and Control of NCDs, scheduled for September 19, 2011, in New York (NY, USA). More...
Of particular concern are the actions of the US, Canada, and the European Union (EU) to block proposals for the inclusion of an overarching goal: to cut preventable deaths from NCDs by 25% by 2025.

The NCD Alliance has therefore called on all member states to grasp the opportunity of the High-Level Meeting and agree to an overarching goal to reduce preventable deaths from NCDs by 25% by 2025; define a clear timeline for tackling the epidemic of the four major NCDs--cancer, cardiovascular disease, diabetes, and chronic respiratory disease; agree on a set of specific, evidence-based targets and global indicators; and form a high-level collaborative initiative of governments and UN agencies with civil society to stimulate and assess progress.

“We have a unique and historic opportunity to change the course of the NCD crisis and stop millions of people around the world suffering unnecessary pain and hardship; to do that, we need every government to agree and act on a common goal,” said Ann Keeling, MD, chair of the NCD Alliance. “The situation is urgent. Yet, it is reported that sound proposals for the draft declaration to include time-bound commitments and targets are being systematically deleted, diluted, and downgraded.”

NCDs are the leading cause of death worldwide, responsible for 36 million deaths in 2008 and accounting for 63% of all global deaths. A significant and growing social and economic threat, the NCD epidemic threatens to devastate families, overwhelm health systems, and slow global economic growth. Over the next 20 years, the NCD epidemic is projected to accelerate exponentially, with a projected 52 million annual deaths by the year 2030.

Related Links:
United Nations
NCD Alliance


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.